Monday, November 2, 2026

LG CNS Partners with W&B to Supercharge AI Operations in Silicon Valley

LG CNS partners with W&B to enhance agentic AI capabilities, focusing on technology sharing and service optimization for corporate clients.

Olympic Star Collapses at Press Conference: What Happened to Kim Ye Ji?

Kim Ye Ji, who won a silver medal in the 10m shooting event at the Paris Olympics, collapsed and lost consciousness during a press conference.

News1

LegoChem expands options beyond early ADC licensing into late-stage clinical development

LegoChem Biosciences secures funding to advance ADC therapies into late-stage trials, enhancing strategic flexibility in biotech.

Partnering Hits 180 Meetings, 2,000 Visitors…Celltrion Showcases AI and ADC Strength at BIO USA

Celltrion showcased AI-driven drug development at BIO USA, holding 180 meetings and emphasizing partnerships in antibody programs.

Big Pharma Turns to AI, China to Capital—What K-Bio Faced in San Diego [BIO USA Wrap-Up]

The BIO International Convention 2026 highlighted AI's role in biotech, emphasizing supply chain shifts and the need for capital investment.

GCCL Strengthens Global Clinical Trial Role: What This Means for Asia’s Biotech Industry?

GCCL aims to expand internationally as a central lab for clinical trials, enhancing services and leveraging competitive advantages.

Revolutionizing Healthcare: How Low-Risk NK Cell Therapy is Changing Regenerative Medicine in 2026

The Ministry of Health reclassifies autologous immune cell cultivation as low risk, expediting treatment access while ensuring safety.

2026 Nature Conference: Exploring the Future of Autonomous Robotics at KAIST

KAIST will host the first Nature Conference on Autonomous Robotics, showcasing innovations and discussions on the future of robotics.

How Hyundai’s 100 Million USD Investment in Boston Dynamics is Set to Transform Robotics and AI by 2027

Boston Dynamics invests $100M in a new robotics and AI center in Massachusetts to streamline operations and boost job creation by 2033.

Lotte Biologics says it has secured top-10 global CDMO manufacturing capacity [BIO USA]

Lotte Biologics is set to begin commercial production by the end of 2026, advancing its capabilities in the global CDMO market.

ABL Bio to Launch Global Phase 3 Trial of Gastric Cancer Drug Givastomig This Year at BIO USA

ABL Bio plans a Phase 3 trial for gastric cancer therapy Givastomig, targeting a $2.5 billion market opportunity.

NVP Healthcare Signs Exclusive Supply Deal for NVP-1702 With Brazil’s Marjan Farma at BIO USA

NVP Healthcare signs a deal with Marjan Farma to supply its probiotic NVP-1702 for liver health products in Brazil, aiming for market expansion.

Shaperon to Expand Biobeauty Business With NeedsTech, Targeting Hong Kong, Taiwan and U.S. Markets

Shaperon is acquiring NeedsTech to enhance its biobeauty business and expand globally, targeting markets in Hong Kong, Taiwan, and the U.S.

From Keycaps to World Cup Matches, K-Bio Turns BIO USA Into a Marketing Showcase

The BIO International Convention 2026 showcased innovative marketing and cultural engagement, enhancing the biotech industry's global appeal.

LG CNS Launches PerfectWin ERP Edition with AI Automation for Enhanced SAP Testing Efficiency

LG CNS launched the Perfect Win ERP Edition, an AI-driven tool that automates SAP ERP testing, enhancing efficiency and reliability.

How Does the EMU-370 Compare to KTX? A Deep Dive into Korea’s Next-Gen High-Speed Rail

The 2026 National Land Transportation Technology Exhibition in Seoul showcases innovations like high-speed trains, driving simulators, and smart construction tech.

Top News

- Our Sponsors Ad -

Follow us